Ann L. Oberg

Harvard University — United States

Medicine · Health Sciences

77h-index21.7kcitations605works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(184), Liver Disease Diagnosis and Treatment(82), Ovarian cancer diagnosis and treatment(70), Chromatin Remodeling and Cancer(66), Endoplasmic Reticulum Stress and Disease(49)

Publications602 total

Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer
PLoS ONE·2026Open Access
Supplementary Table S4 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Table S3 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Table S7 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Table S2 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Figure S1 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Table S1 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Table S6 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Table S8 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Data from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Figure S2 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Supplementary Table S5 from Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
2026Open Access
Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR)
Clinical Cancer Research·2026Open Access
Laboratory Signs of CKD after Preeclampsia
Journal of the American Society of Nephrology·2026
Supplementary Methods and Tables 1-3 from Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives
2025Open Access
Supplementary Table S5 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S4 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S1 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S3 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
page 1 of 31Next →

Frequent Co-authors

Sundeep Khosla(11), Sara J. Achenbach(10), B. Lawrence Riggs(8), Lynn C. Hartmann(7), Elizabeth J. Atkinson(6), Kimberly R. Kalli(5), Gloria M. Petersen(5), L. Joseph Melton(5), Kari G. Chaffee(5), Matthew J. Maurer(5), L. Joseph Melton(4), Stephen N. Thibodeau(4), Julie M. Cunningham(4), William R. Bamlet(4), L. Joseph Melton(3), Keith L. Knutson(3), Aaron L. Sarver(3), Yan W. Asmann(3), Brian M. Wolpin(3), Paige M. Bracci(3)